These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2703841)

  • 81. Cerebrospinal fluid complement proteins in neurological disease.
    Price P; Cuzner ML
    J Neurol Sci; 1980 Apr; 46(1):49-54. PubMed ID: 6966324
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Ventriculo-lumbar gradient of concentration of total cerebrospinal fluid proteins: 1 - mechanisms of origin].
    Braga FM; dos Reis-Filho JB; de Camargo-Lima JG
    Arq Neuropsiquiatr; 1983 Sep; 41(3):254-65. PubMed ID: 6651573
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis.
    Overbosch D; van de Nes JC; Groll E; Diekmann HW; Polderman AM; Mattie H
    Eur J Clin Pharmacol; 1987; 33(3):287-92. PubMed ID: 3691616
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability.
    Cserr HF; DePasquale M; Harling-Berg CJ; Park JT; Knopf PM
    J Neuroimmunol; 1992 Dec; 41(2):195-202. PubMed ID: 1469079
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunoglobulins and complement components in 37 patients infected by HIV-1 virus: comparison of general (systemic) and intrathecal immunity.
    Reboul J; Schuller E; Pialoux G; Rey MA; Lebon P; Allinquant B; Brun-Vezinet F
    J Neurol Sci; 1989 Feb; 89(2-3):243-52. PubMed ID: 2926452
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ataxic hemiparesis from parenchymal brain cysticercosis.
    Barinagarrementeria F; Del Brutto OH
    J Neurol; 1988 May; 235(5):325. PubMed ID: 3385454
    [No Abstract]   [Full Text] [Related]  

  • 87. The cerebrospinal fluid C4 complement component in different meningeal and neurological diseases.
    Mavrikakis M; Papageorgiou C; Kondou I; Chondrokoukis N; Pavlatou M
    Acta Neurol Scand; 1980 Nov; 62(5):276-81. PubMed ID: 6781211
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Acute pancytopenia due to praziquantel treatment for cerebral cysticercosis: A rare case report.
    Zhang Y; Fu Y; Deng H; Li Q; Lai J
    J Infect Chemother; 2020 Oct; 26(10):1082-1085. PubMed ID: 32600852
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Therapeutic Trial Of Praziquantal (Embay 8440; Biltricide(R)) On The Dermal And Cerebral Human Cysticercosis.
    Rim HJ; Lee JS; Joo KH; Kim SJ; Won CR; Park CY
    Kisaengchunghak Chapchi; 1982 Dec; 20(2):169-190. PubMed ID: 12902689
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury.
    Kossmann T; Stahel PF; Morganti-Kossmann MC; Jones JL; Barnum SR
    J Neuroimmunol; 1997 Mar; 73(1-2):63-9. PubMed ID: 9058760
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serologic follow-up study in neurocysticercosis patients by ELISA after praziquantel treatment.
    Cho SY; Kim SI; Kang SY
    Kisaengchunghak Chapchi; 1986 Dec; 24(2):159-170. PubMed ID: 12886092
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Immunological and molecular diagnosis of cysticercosis.
    Rodriguez S; Wilkins P; Dorny P
    Pathog Glob Health; 2012 Sep; 106(5):286-98. PubMed ID: 23265553
    [TBL] [Abstract][Full Text] [Related]  

  • 93. CSF/serum quotient graphs for the evaluation of intrathecal C4 synthesis.
    Padilla-Docal B; Dorta-Contreras AJ; Bu-Coifiu-Fanego R; Rey AR
    Cerebrospinal Fluid Res; 2009 Jul; 6():8. PubMed ID: 19573230
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.
    Rodriguez S; Dorny P; Tsang VC; Pretell EJ; Brandt J; Lescano AG; Gonzalez AE; Gilman RH; Garcia HH;
    J Infect Dis; 2009 May; 199(9):1345-52. PubMed ID: 19358669
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci.
    Bueno EC; Snege M; Vaz AJ; Leser PG
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1140-4. PubMed ID: 11687454
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Specific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples.
    Bueno EC; Vaz AJ; Machado LD; Livramento JA; Mielle SR
    J Clin Microbiol; 2000 Jan; 38(1):146-51. PubMed ID: 10618078
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen.
    Jung H; Medina R; Castro N; Corona T; Sotelo J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1256-9. PubMed ID: 9174180
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Neurocysticercosis.
    Pittella JE
    Brain Pathol; 1997 Jan; 7(1):681-93. PubMed ID: 9034574
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Use of enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot for the diagnosis and monitoring of neurocysticercosis.
    Simac C; Michel P; Andriantsimahavandy A; Esterre P; Michault A
    Parasitol Res; 1995; 81(2):132-6. PubMed ID: 7731920
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.